Classification
- Anatomical main groupDDermatologicals
- Therapeutic subgroupD05
- Pharmacological subgroupD05B
- Chemical subgroupD05BA
- Chemical substanceD05BA02Methoxsalen
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 6 registrations
- Uvadex20 MCG / ML · Solution · Therakos LLC
- Oxsoralen Cap 10MG10 MG · Capsule · Valeant Canada LP / Valeant Canada S.E.C.
- Oxsoralen Lot 10MG/ML10 MG / ML · Lotion · Valeant Canada LP / Valeant Canada S.E.C.
- Oxsoralen-Ultra Cap 10MG10 MG · Capsule · Valeant Canada LP / Valeant Canada S.E.C.
Spain
AEMPS · 5 registrations
At a glance
- ATC code
- D05BA02
- ATC group
- Dermatologicals
- Registers
- 5
- Historical lists
- 1
- Registrations
- 21
- With their own page
- 12
- Companies
- 14
All medicines with Methoxsalen
Human medicines from every register that match Methoxsalen by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
21 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Methoxsalen | United States | 10MG | capsule | Marketed | Ani Pharms |
| Oxsoralen-Ultra | United States | 10MG | capsule | Marketed | Bausch |
| Uvadex | United States | 0.02MG/ML | injectable | Marketed | Therakos Development |
| Oxsoralen | United States | 1% | lotion | Not marketed | Valeant Pharm Intl |
| 8-Mop | United States | 10MG | capsule | Not marketed | Valeant Pharm Intl |
| Metoxaleno G.L. Pharma 20 Microgramos/ML Solucion Para Modificacion de Las Fracciones Sanguineas | Spain | 20 microgramos/ml | solución para modificación de las fracciones sanguíneas | Marketed | G.L. Pharma Gmbh |
| Metoxaleno Macopharma 20 Microgramos/ML Solucion Para Modificacion de Las Fracciones Sanguineas | Spain | 20 microgramos/ml | solución para modificación de las fracciones sanguíneas | Marketed | Maco Pharma |
| UVADEX 20 microgramos/ml SOLUCION PARA MODIFICACION DE LAS FRACCIONES SANGUINEAS | Spain | 20 µg | solución para modificación de las fracciones sanguíneas | Marketed | Therakos Europe Limited |
| Metoxaleno S.A.L.F. 20 Microgramos/ML Solucion Para Modificacion de Las Fracciones Sanguineas | Spain | 20 microgramos/ml | solución para modificación de las fracciones sanguíneas | Authorised | S.A.L.F. S.P.A. Laboratorio Farmacologico |
| Uvadex 20 microgram/ml oplossing voor het modificeren van een bloedfractie | Netherlands | Oplossing voor het modificeren van een bloedfractie | Authorised | Therakos Europe Limited | |
| Uvadex | Canada | 20 MCG / ML | Solution | Marketed | Therakos LLC |
| Any | New Zealand | Lotn 1.2% | Funded | ||
| Oxsoralen Lotion | Saudi Arabia | Authorised | I.C.N.Pharmaceuticals | ||
| Oxsoralen Caps 10MG | Saudi Arabia | Authorised | I.C.N.Pharmaceuticals | ||
| Neo Meladinine F.R Tab 10MG | Saudi Arabia | Authorised | Memphis Chemicals | ||
| Oxsoralen | Spain | 10 mg | cápsula dura | Suspended | Laboratorios Galderma S.A. |
| Oxsoralen Lot 10MG/ML | Canada | 10 MG / ML | Lotion | Cancelled | Valeant Canada LP / Valeant Canada S.E.C. |
| Oxsoralen Cap 10MG | Canada | 10 MG | Capsule | Cancelled | Valeant Canada LP / Valeant Canada S.E.C. |
| Oxsoralen-Ultra Cap 10MG | Canada | 10 MG | Capsule | Cancelled | Valeant Canada LP / Valeant Canada S.E.C. |
| Ultra Mop Lotion 1% | Canada | 1 % / % | Liquid | Cancelled | Canderm G.P. |
| Ultramop Cap 10MG | Canada | 10 MG | Capsule | Cancelled | Canderm G.P. |